BRPI0713501A2 - composições antibacterianas - Google Patents
composições antibacterianas Download PDFInfo
- Publication number
- BRPI0713501A2 BRPI0713501A2 BRPI0713501-7A BRPI0713501A BRPI0713501A2 BR PI0713501 A2 BRPI0713501 A2 BR PI0713501A2 BR PI0713501 A BRPI0713501 A BR PI0713501A BR PI0713501 A2 BRPI0713501 A2 BR PI0713501A2
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- hydrogen
- optionally substituted
- antibacterial compositions
- antibacterial
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000006413 ring segment Chemical group 0.000 abstract 1
- 150000003568 thioethers Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0612428.3 | 2006-06-22 | ||
| GBGB0612428.3A GB0612428D0 (en) | 2006-06-22 | 2006-06-22 | Antibacterial agents |
| PCT/GB2007/002314 WO2007148093A1 (en) | 2006-06-22 | 2007-06-21 | Antibacterial compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0713501A2 true BRPI0713501A2 (pt) | 2012-03-13 |
Family
ID=36803739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0713501-7A BRPI0713501A2 (pt) | 2006-06-22 | 2007-06-21 | composições antibacterianas |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US7977340B2 (enExample) |
| EP (1) | EP2034997B1 (enExample) |
| JP (1) | JP5309021B2 (enExample) |
| KR (1) | KR101443795B1 (enExample) |
| CN (1) | CN101472585B (enExample) |
| AU (1) | AU2007262791B2 (enExample) |
| BR (1) | BRPI0713501A2 (enExample) |
| CA (1) | CA2655403C (enExample) |
| DK (1) | DK2034997T3 (enExample) |
| EA (1) | EA019748B1 (enExample) |
| ES (1) | ES2403005T3 (enExample) |
| GB (1) | GB0612428D0 (enExample) |
| IL (1) | IL195687A (enExample) |
| MX (1) | MX2008015706A (enExample) |
| MY (1) | MY148682A (enExample) |
| NZ (1) | NZ574313A (enExample) |
| PL (1) | PL2034997T3 (enExample) |
| PT (1) | PT2034997E (enExample) |
| SG (1) | SG172676A1 (enExample) |
| WO (1) | WO2007148093A1 (enExample) |
| ZA (1) | ZA200900240B (enExample) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8481544B2 (en) | 2006-06-22 | 2013-07-09 | Biota Europe Limited | Antibacterial compositions |
| GB0724349D0 (en) * | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Antibacterial agents |
| GB0612428D0 (en) | 2006-06-22 | 2006-08-02 | Prolysis Ltd | Antibacterial agents |
| BRPI0720057A2 (pt) | 2006-12-04 | 2013-12-17 | Astrazeneca Ab | Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos de inibição de girase bacteriana de dna e/ou topoisomerase iv bacteriana em um animal de sangue quente, de produção de um efeito antibacteriano em um animal de sangue quente e de tratamento de uma infecção bacteriana em um animal de sangue quente, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo |
| GB0724342D0 (en) | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Anitbacterial compositions |
| DE102008022221A1 (de) | 2008-05-06 | 2009-11-12 | Universität des Saarlandes | Inhibitoren der humanen Aldosteronsynthase CYP11B2 |
| EP2296653B1 (en) | 2008-06-03 | 2016-01-27 | Intermune, Inc. | Compounds and methods for treating inflammatory and fibrotic disorders |
| US20110166088A1 (en) * | 2008-06-25 | 2011-07-07 | Ranbaxy Laboratories Limited | Benzothiazoles and aza-analogues thereof use as antibacterial agents |
| GB0821913D0 (en) | 2008-12-02 | 2009-01-07 | Price & Co | Antibacterial compounds |
| EP2277870A1 (de) * | 2009-06-24 | 2011-01-26 | Bayer CropScience AG | Substituierte Benzoxa(thia)zole |
| US8541404B2 (en) | 2009-11-09 | 2013-09-24 | Elexopharm Gmbh | Inhibitors of the human aldosterone synthase CYP11B2 |
| KR20130012072A (ko) | 2010-03-31 | 2013-01-31 | 액테리온 파마슈티칼 리미티드 | 항박테리아성 이소퀴놀린-３-일우레아 유도체 |
| WO2011151619A1 (en) | 2010-06-01 | 2011-12-08 | Summit Corporation Plc | Compounds for the treatment of clostridium difficile associated disease |
| SI2575968T1 (sl) | 2010-06-01 | 2016-06-30 | Summit Therapeutics Plc | Spojine za zdravljenje bolezni, ki je povezana s clostridium difficile |
| WO2011151620A1 (en) | 2010-06-01 | 2011-12-08 | Summit Corporation Plc | Compounds for the treatment of clostridium difficile associated disease |
| WO2011151617A1 (en) | 2010-06-01 | 2011-12-08 | Summit Corporation Plc | Compounds for the treatment of clostridium difficile associated disease |
| WO2011151618A2 (en) | 2010-06-01 | 2011-12-08 | Summit Corporation Plc | Compounds for the treatment of clostridium difficile-associated disease |
| SG191946A1 (en) | 2011-01-14 | 2013-08-30 | Vertex Pharma | Pyrimidine gyrase and topoisomerase iv inhibitors |
| ES2705923T3 (es) | 2011-01-14 | 2019-03-27 | Spero Trinem Inc | Formas sólidas de inhibidor de girasa (R)-1-etil-3-[6-fluoro-5-[2-(1-hidroxi-1-metil-etil)pirimidin-5-il]-7-(tetrahidrofuran-2-il)-1H-bencimidazol-2-il]urea |
| EP2663558A1 (en) | 2011-01-14 | 2013-11-20 | Vertex Pharmaceuticals Incorporated | Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urea |
| EP2663556B1 (en) | 2011-01-14 | 2014-10-15 | Vertex Pharmaceuticals Incorporated | Process of making gyrase and topoisomerase iv inhibitors |
| AR088729A1 (es) | 2011-03-29 | 2014-07-02 | Actelion Pharmaceuticals Ltd | Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica |
| CN103702994B (zh) | 2011-06-20 | 2016-03-23 | 沃泰克斯药物股份有限公司 | 旋转酶和拓扑异构酶抑制剂的磷酸酯 |
| WO2013106756A2 (en) | 2012-01-13 | 2013-07-18 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| EP2828245A1 (en) | 2012-03-21 | 2015-01-28 | Rutgers, The State University of New Jersey | Antimicrobial agents |
| CN104302645A (zh) * | 2012-03-22 | 2015-01-21 | 生物区欧洲有限公司 | 抗菌化合物 |
| US9572809B2 (en) | 2012-07-18 | 2017-02-21 | Spero Trinem, Inc. | Combination therapy to treat Mycobacterium diseases |
| WO2014015105A1 (en) | 2012-07-18 | 2014-01-23 | Vertex Pharmaceuticals Incorporated | Solid forms of (r)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1h-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof |
| US9079935B2 (en) | 2012-08-13 | 2015-07-14 | The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas | Reducing risk of contracting Clostridium-difficile associated disease |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| US20160194279A1 (en) * | 2012-12-09 | 2016-07-07 | Council Of Scientific & Industrial Research | One pot process for the conversion of aroyl chlorides to acyl thioureas |
| US9458150B2 (en) | 2013-11-08 | 2016-10-04 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| BR112016018048A2 (pt) | 2014-02-03 | 2017-08-08 | Spero Gyrase Inc | Método para o tratamento ou prevenção de uma infecção bacteriana, uso de um inibidor de topoisomerase tipo ii bacteriana em combinação com uma polimixina ou derivado de polimixina no tratamento ou prevenção de uma infecção bacteriana, uso de um inibidor de topoisomerase tipo ii bacteriana em combinação com uma polimixina ou derivado de polimixina na preparação de um medicamento para o tratamento ou prevenção de uma infecção bacteriana, método para melhorar a atividade antibacteriana de um inibidor de topoisomerase tipo ii bacteriana, método para melhorar a eficácia bactericida de um inibidor de topoisomerase tipo ii bacteriana, composição, agente antibacteriano, processo, e, composto |
| RU2692485C2 (ru) | 2014-04-02 | 2019-06-25 | Интермьюн, Инк. | Противофиброзные пиридиноны |
| BR112017011791A2 (pt) * | 2014-12-02 | 2018-02-27 | Bayer Cropscience Aktiengesellschaft | compostos bicíclicos como agentes de controle de pragas |
| US20180000793A1 (en) | 2015-02-06 | 2018-01-04 | Ernesto Abel-Santos | Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis |
| AR104259A1 (es) | 2015-04-15 | 2017-07-05 | Celgene Quanticel Res Inc | Inhibidores de bromodominio |
| CN106167486B (zh) * | 2015-05-22 | 2019-06-14 | 北京四环制药有限公司 | 单环类回旋酶和拓扑异构酶iv抑制剂 |
| CA3015768A1 (en) | 2016-02-25 | 2017-08-31 | Taxis Pharmaceuticals, Inc. | Synthetic processes and intermediates |
| MX2019008230A (es) | 2017-01-10 | 2019-10-24 | Bayer Ag | Derivados heterociclicos como agentes de control de plagas. |
| RU2019133662A (ru) | 2017-03-24 | 2021-04-26 | Тайсо Фармасьютикал Ко., Лтд. | Производное 2(1h)-хинолинона |
| EP3600298A4 (en) | 2017-03-30 | 2020-11-11 | Taxis Pharmaceuticals, Inc. | SYNTHESIS AND SYNTHESIS INTERMEDIARIES |
| TWI820231B (zh) | 2018-10-11 | 2023-11-01 | 德商拜耳廠股份有限公司 | 用於製備經取代咪唑衍生物之方法 |
| EP3999502A1 (en) | 2019-07-17 | 2022-05-25 | Summit (Oxford) Limited | Process for the preparation of ridinilazole and crystalline forms thereof |
| US20230247994A1 (en) | 2020-07-02 | 2023-08-10 | Bayer Aktiengesellschaft | Heterocyclene derivatives as pest control agents |
| GB202100470D0 (en) | 2021-01-14 | 2021-03-03 | Summit Oxford Ltd | Solid tablet dosage for of ridinilazole |
| GB202100471D0 (en) | 2021-01-14 | 2021-03-03 | Summit Oxford Ltd | Preparation of antibacterial compounds |
| US12220421B2 (en) | 2021-09-09 | 2025-02-11 | The Boards Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las | Inhibitors of C. difficile spore germination |
| CN116444376B (zh) * | 2023-04-19 | 2024-01-26 | 德兴市德邦化工有限公司 | 一种3,5-二氯硝基苯的生产工艺 |
| WO2025026738A1 (en) | 2023-07-31 | 2025-02-06 | Bayer Aktiengesellschaft | 6-[5-(ethylsulfonyl)-1-methyl-1h-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7h-imidazo[4,5-c]pyridazine derivatives as pesticides |
| CN119350937B (zh) * | 2024-10-30 | 2025-08-12 | 广东豪之盛新材料有限公司 | 一种双组份气雾喷漆及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3810988A (en) * | 1968-11-01 | 1974-05-14 | Ciba Geigy Ag | Control of phytopathogenic fungi with n-benzothiazae-2-yl n-{40 {11 propylure |
| CH505543A (de) * | 1968-11-01 | 1971-04-15 | Ciba Geigy Ag | Schädlingsbekämpfungsmittel |
| US4028374A (en) * | 1975-11-03 | 1977-06-07 | Morton-Norwich Products, Inc. | Antibacterial thiocyanatobenzothiazoles |
| US7091227B2 (en) | 2000-02-07 | 2006-08-15 | Abbott Gmbh & Co. Kg | Benzothiazole derivatives |
| BR0112395A (pt) | 2000-06-21 | 2003-07-08 | Hoffmann La Roche | Derivados de benzotiazol |
| SI1341769T1 (sl) | 2000-12-15 | 2008-02-29 | Vertex Pharma | Inhibitorji bakterijske giraze in njihove uporabe |
| AR042956A1 (es) * | 2003-01-31 | 2005-07-13 | Vertex Pharma | Inhibidores de girasa y usos de los mismos |
| US20050130974A1 (en) * | 2003-10-17 | 2005-06-16 | Rigel Pharmaceuticals, Inc. | Benzothiazole compositions and their use as ubiquitin ligase inhibitors |
| EP1790640A4 (en) * | 2004-09-09 | 2009-07-29 | Chugai Pharmaceutical Co Ltd | NEW IMIDAZOLIDINE DERIVATIVE AND APPLICATION THEREOF |
| GB0612428D0 (en) | 2006-06-22 | 2006-08-02 | Prolysis Ltd | Antibacterial agents |
-
2006
- 2006-06-22 GB GBGB0612428.3A patent/GB0612428D0/en not_active Ceased
-
2007
- 2007-06-21 KR KR1020097001499A patent/KR101443795B1/ko not_active Expired - Fee Related
- 2007-06-21 JP JP2009515958A patent/JP5309021B2/ja not_active Expired - Fee Related
- 2007-06-21 EA EA200900047A patent/EA019748B1/ru not_active IP Right Cessation
- 2007-06-21 CN CN200780023251XA patent/CN101472585B/zh not_active Expired - Fee Related
- 2007-06-21 PL PL07733310T patent/PL2034997T3/pl unknown
- 2007-06-21 MY MYPI20085070 patent/MY148682A/en unknown
- 2007-06-21 DK DK07733310T patent/DK2034997T3/da active
- 2007-06-21 EP EP20070733310 patent/EP2034997B1/en not_active Not-in-force
- 2007-06-21 AU AU2007262791A patent/AU2007262791B2/en not_active Ceased
- 2007-06-21 WO PCT/GB2007/002314 patent/WO2007148093A1/en not_active Ceased
- 2007-06-21 US US12/304,303 patent/US7977340B2/en not_active Expired - Fee Related
- 2007-06-21 SG SG2011040847A patent/SG172676A1/en unknown
- 2007-06-21 BR BRPI0713501-7A patent/BRPI0713501A2/pt not_active IP Right Cessation
- 2007-06-21 MX MX2008015706A patent/MX2008015706A/es active IP Right Grant
- 2007-06-21 ES ES07733310T patent/ES2403005T3/es active Active
- 2007-06-21 NZ NZ574313A patent/NZ574313A/en not_active IP Right Cessation
- 2007-06-21 PT PT07733310T patent/PT2034997E/pt unknown
- 2007-06-21 CA CA2655403A patent/CA2655403C/en not_active Expired - Fee Related
-
2008
- 2008-12-03 IL IL195687A patent/IL195687A/en active IP Right Grant
-
2009
- 2009-01-12 ZA ZA2009/00240A patent/ZA200900240B/en unknown
-
2011
- 2011-06-07 US US13/154,592 patent/US8389516B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| SG172676A1 (en) | 2011-07-28 |
| US20110263590A1 (en) | 2011-10-27 |
| WO2007148093A1 (en) | 2007-12-27 |
| KR20090029817A (ko) | 2009-03-23 |
| IL195687A (en) | 2013-12-31 |
| US8389516B2 (en) | 2013-03-05 |
| AU2007262791B2 (en) | 2012-11-08 |
| EA200900047A1 (ru) | 2009-06-30 |
| JP2009541289A (ja) | 2009-11-26 |
| PL2034997T3 (pl) | 2013-04-30 |
| GB0612428D0 (en) | 2006-08-02 |
| ES2403005T3 (es) | 2013-05-13 |
| CA2655403A1 (en) | 2007-12-27 |
| KR101443795B1 (ko) | 2014-10-21 |
| AU2007262791A1 (en) | 2007-12-27 |
| MX2008015706A (es) | 2009-03-31 |
| CN101472585B (zh) | 2013-12-04 |
| IL195687A0 (en) | 2009-09-01 |
| US7977340B2 (en) | 2011-07-12 |
| DK2034997T3 (da) | 2013-02-11 |
| EA019748B1 (ru) | 2014-06-30 |
| EP2034997A1 (en) | 2009-03-18 |
| MY148682A (en) | 2013-05-31 |
| CA2655403C (en) | 2014-02-04 |
| CN101472585A (zh) | 2009-07-01 |
| JP5309021B2 (ja) | 2013-10-09 |
| US20090197877A1 (en) | 2009-08-06 |
| PT2034997E (pt) | 2013-01-24 |
| EP2034997B1 (en) | 2012-10-17 |
| ZA200900240B (en) | 2009-12-30 |
| NZ574313A (en) | 2011-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0713501A2 (pt) | composições antibacterianas | |
| BR0316496A (pt) | Quinolin-, isoquinolin-, e quinazolin-oxialquilamidas e seu emprego como fungicidas | |
| FR2865135B1 (fr) | Installation de sterilisation d'articles par bombardement electronique | |
| PL2662448T3 (pl) | Kierowana do kości fosfataza alkaliczna, zestawy i sposoby jej zastosowania | |
| BRPI0518301A2 (pt) | inseticidas | |
| BRPI0411528A (pt) | uso de isomalte como prebiótico | |
| EA201000993A1 (ru) | Конденсированные тиазолы, обладающие антибактериальными свойствами | |
| ECSP099413A (es) | COMPUESTOS A BASE DE 4 - fenil - 6 - (2,2,2 - trifluoro - 1 - feniletoxi)pirimidina Y MÉTODOS PARA SU EMPLEO | |
| CR9375A (es) | Derivados de ciclopropanocarboxamida | |
| MX2009003129A (es) | Derivados de oxadiazol con propiedades anti-inflamatorias e inmunosupresoras. | |
| BRPI0607220A2 (pt) | dispositivo de proteção auricular com material de amortecimento | |
| ES2530398T3 (es) | Pirrolidin-2-onas 4-sustituidas y su uso | |
| IL190972A0 (en) | Updating multiple levels of translation lookaside buffers (tlbs) field | |
| BRPI0413467A (pt) | aminopironas e seu uso como inibidoras da atm | |
| ATE556475T1 (de) | Oberflächenmontierte perimeterkabelkanal- versatzbaugruppe | |
| CR10303A (es) | "derivados de quinolina y su uso com pesticidas" | |
| ATE541461T1 (de) | Synergistische wirkstoffkombinationen | |
| ATE505083T1 (de) | Fungizide mischungen | |
| BR0113970A (pt) | Compostos de pirimidina e seu uso | |
| DK1135403T3 (da) | 17beta-acyl-17alfa-propynyl-11beta-arylsteroider og deres derivater med agonistiske eller antagonistiske hormonale egenskaber | |
| BRPI1016167A2 (pt) | compostos heterocíclicos antivirais. | |
| SV2009002927A (es) | Combinacion fungicidas de principios activos | |
| ATE528284T1 (de) | Metallcarbamate aus tolylendiaminen | |
| CR8177A (es) | Compuestos de 3- arilpiridina arilcondensados y su empleo para combatir hongos nocivos | |
| BRPI0415285A (pt) | derivados de aminoalcanol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: BIOTA EUROPE LIMITED (GB) Free format text: TRANSFERIDO DE: PROLYSIS LIMITED |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |